Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
about
Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision MedicineThe unfolded protein response in neurodegenerative diseases: a neuropathological perspectiveNeuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?Enhanced Fibril Fragmentation of N-Terminally Truncated and Pyroglutamyl-Modified Aβ Peptides.Protective Effects of Wogonin against Alzheimer's Disease by Inhibition of Amyloidogenic Pathway.Electron tomography reveals the fibril structure and lipid interactions in amyloid deposits.Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer's disease pathology.Clinical-pathologic correlations in vascular cognitive impairment and dementiaMolecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy.Amyloid β-peptides interfere with mitochondrial preprotein import competence by a coaggregation process.Amyloid plaque structure and cell surface interactions of β-amyloid fibrils revealed by electron tomography.Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms.Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?Gastrodin Protects Neural Progenitor Cells Against Amyloid β (1-42)-Induced Neurotoxicity and Improves Hippocampal Neurogenesis in Amyloid β (1-42)-Injected Mice.Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders.Alzheimer's disease: experimental models and reality.Phosphorylation Interferes with Maturation of Amyloid-β Fibrillar Structure in the N Terminus.Isotope-edited FTIR reveals distinct aggregation and structural behaviors of unmodified and pyroglutamylated amyloid β peptides.The role of melatonin in the onset and progression of type 3 diabetes.A mix-and-click method to measure amyloid-β concentration with sub-micromolar sensitivity.Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.Clearance of amyloid β-protein and its role in the spreading of Alzheimer's disease pathology.Factors affecting the physical stability (aggregation) of peptide therapeutics.Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid.Pericyte implantation in the brain enhances cerebral blood flow and reduces amyloid-β pathology in amyloid model mice.Pyroglutamate-Modified Amyloid β (11- 40) Fibrils Are More Toxic than Wildtype Fibrils but Structurally Very Similar.SODA: prediction of protein solubility from disorder and aggregation propensity.Effects and mechanism of amyloid β1-42 on mitochondria in astrocytes.Nanogels of dual inhibitor-modified hyaluronic acid function as a potent inhibitor of amyloid β-protein aggregation and cytotoxicity.
P2860
Q26768648-09B8A6E3-BF9A-4A8C-88CD-699DD7BA8712Q26799511-1A860F4D-75BC-47C5-8DD6-9B7E881BBE8DQ28070156-F3FC1D68-BA06-4D84-8068-161A663D1D75Q30315438-3A9C477D-BDD8-4BB5-BC7B-0D75DDA3951DQ33819805-97DE6F75-4752-4CF3-B0D3-D3A86DDB9A9FQ36007352-3927D272-4533-4A91-9479-C925B06CEEC2Q36433202-57E17FC2-26FA-4D23-9572-6A838C611CF0Q36627110-9E758D0D-FAFC-4B30-9445-5DF0FF0E926EQ36771721-40D4B87A-1210-4127-A6C5-EC534BDF84B9Q36786388-5FB49E8F-67D6-489E-B223-9A7741FA1C78Q37518239-6EEA0BE2-A546-43A0-9C52-BD7AFA4BE70FQ37668087-31AD4003-74FA-4ADE-B25D-5A7A7F773395Q37694473-079F2AC3-5EB7-4AC2-AF7E-BF059D6B05A7Q38682621-D082BAC6-29D4-4FAF-BC11-F5C45119B204Q38693441-250C3CD8-D5EE-4426-A586-A93C35526495Q38775572-E0F9AC45-4DA1-4827-8DDA-3425B6C8E745Q39003857-863A6394-ACC0-477F-B252-C242B1BEA97CQ39057135-094E5839-254F-4223-AE73-A935E3F8D0ACQ39716461-23FBDD7C-9D7D-4E9E-81F1-D314C04D4574Q40692757-FC4D420B-3668-41A8-BE51-C368763ED3C4Q41206619-22345AA6-F318-47F0-823A-68BC67AA1650Q41580596-DC80F6F5-237F-452D-82BB-F5D5D32AD1E7Q41592614-ED4AB9CB-E9B3-40D4-B159-E6D610591843Q43145363-815EB735-946A-4A07-B85F-1B7FE695058BQ46259884-A6178E9F-AEAD-4CCD-9E44-5D65EB06DE49Q47279111-D6C0CE92-B393-41FD-A78A-C291A531004DQ47437348-3AFF9346-5381-4C25-97A1-FF2B92779B68Q48132995-A1D363B6-8226-438B-A5AA-B1BC37031C68Q50874930-5CFE6053-F008-43A4-BD64-C84C8476B343Q52641285-03BA6110-B231-4075-BC07-F89BD4E279ACQ55006962-E3A19041-ECEC-4C4B-B4B6-107E897339ED
P2860
Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
@en
type
label
Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
@en
prefLabel
Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
@en
P2093
P2860
P1476
Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease
@en
P2093
Jochen Walter
Marcus Fändrich
Takaomi C Saido
P2860
P2888
P304
P356
10.1007/S00401-014-1375-Y
P577
2014-12-23T00:00:00Z
P6179
1024601435